Noninvasive liver fibrosis assessment in metabolic dysfunction-associated steatotic liver disease

doi:10.4254/wjh.v18.i1.111534

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-2)

Sum=5

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=0

Jan 27, 2026 (publication date) through Jan 27, 2026

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Jan 27, 2026; 18(1): 111534
Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.111534

Open in New Tab Full Size Figure Download Figure

Figure 1 Proposed algorithm for noninvasive assessment of the risk of advanced fibrosis in patients suspected of metabolic dysfunction-associated steatotic liver disease. A: T2 diabetes mellitus (T2DM); B: Abdominal obesity and ≥ 1 additional cardiometabolic risk factor or persistently elevated enzymes. ¹Fibrosis-4 index (FIB-4) threshold valid for age ≤ 65 years (for age > 65 years: The lower FIB-4 cutoff is 2.0). AF: Advanced fibrosis; ELF: Enhanced liver fibrosis; GI: Gastrointestinal; MRE: Magnetic resonance elastography; SWE: Shear-wave elastography; VCTE: Vibration-controlled transient elastography.

Citation: Ribeiro TCR, de Paula Boechat Soares V, Campos Fabri J, de Aragão Ramos LE. Noninvasive liver fibrosis assessment in metabolic dysfunction-associated steatotic liver disease. World J Hepatol 2026; 18(1): 111534
URL: https://www.wjgnet.com/1948-5182/full/v18/i1/111534.htm
DOI: https://dx.doi.org/10.4254/wjh.v18.i1.111534